Edition:
United Kingdom

Sartorius Stedim Biotech SA (STDM.PA)

STDM.PA on Paris Stock Exchange

73.25EUR
23 Feb 2018
Change (% chg)

€1.40 (+1.95%)
Prev Close
€71.85
Open
€71.75
Day's High
€73.80
Day's Low
€71.25
Volume
88,477
Avg. Vol
56,627
52-wk High
€74.40
52-wk Low
€50.13

Chart for

About

Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and... (more)

Overall

Beta: 0.51
Market Cap(Mil.): €5,404.52
Shares Outstanding(Mil.): 92.18
Dividend: 0.42
Yield (%): 0.72

Financials

  Industry Sector
P/E (TTM): -- 32.19 16.60
EPS (TTM): -- -- --
ROI: -- 13.90 10.66
ROE: -- 16.72 14.30

BRIEF-Sartorius Stedim Biotech 2017 Underlying EBITDA Up By 2.2%

* SARTORIUS STEDIM BIOTECH TARGETS CONTINUED PROFITABLE GROWTH - SALES REVENUE PROJECTED AT AROUND 2.8 BILLION EUROS IN 2025

21 Feb 2018

BRIEF-Sartorius Stedim Biotech Proposes Dividend For Fiscal 2017 Of 0.46 Euro Per Share

* ‍UNDER THIS PROPOSAL, TOTAL PROFIT DISTRIBUTED WOULD RISE BY 9.5% FROM EUR 38.7 MILLION TO EUR 42.4 MILLION.​ Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

15 Feb 2018

BRIEF-Sartorius Stedim Biotech FY EBITDA Up At ‍​294.9 Million Euros

* FY EBITDA EUR ‍​294.9 MILLION VERSUS EUR 288.7 MILLION YEAR AGO

31 Jan 2018

BRIEF-Abzena Selects Sartorius Stedim Biotech To Equip Sites In San Diego And Bristol

* ABZENA SELECTS SARTORIUS STEDIM BIOTECH TO EQUIP US BASED DVLPT AND MANUFACTURING SITES IN SAN DIEGO AND BRISTOL

04 Jan 2018

BRIEF-Sartorius Stedim Biotech 9-month EBITDA up at ‍​216.2 million euros

* 9 MONTHS SALES REVENUE EUR 806.5 ‍​ MILLION VERSUS EUR 785.1 MILLION YEAR AGO

25 Oct 2017

BRIEF-Sartorius Stedim Biotech Lothar Kappich appointed to board

* Sartorius Stedim Biotech: Lothar Kappich appointed to the board of directors Source text for Eikon: Further company coverage:

18 Sep 2017

Earnings vs. Estimates